Veitenheimer B, Osborn JW. Effects of intrathecal kynurenate on arterial pressure during chronic osmotic stress in conscious rats. Am J Physiol Heart Circ Physiol 304: H303-H310, 2013. First published November 16, 2012 doi:10.1152/ajpheart.00629.2012.-Increased plasma osmolality elevates mean arterial pressure (MAP) through activation of the sympathetic nervous system, but the neurotransmitters released in the spinal cord to regulate MAP during osmotic stress remain unresolved. Glutamatergic neurons of the rostral ventrolateral medulla project to sympathetic preganglionic neurons in the spinal cord and are likely activated during conditions of osmotic stress; however, this has not been examined in conscious rats. This study investigated whether increased MAP during chronic osmotic stress depends on activation of spinal glutamate receptors. Rats were chronically instrumented with an indwelling intrathecal (i.t.) catheter for antagonist delivery to the spinal cord and a radiotelemetry transmitter for continuous monitoring of MAP and heart rate. Osmotic stress induced by 48 h of water deprivation (WD) increased MAP by ϳ15 mmHg. Intrathecal kynurenic acid, a nonspecific antagonist of ionotropic glutamate receptors, decreased MAP significantly more after 48 h of WD compared with the water-replete state. Water-deprived rats also showed a greater fall in MAP in response to i.t. 2-amino-5-phosphonovalerate. Finally, i.t. kynurenic acid also decreased MAP more in an osmotically driven model of neurogenic hypertension, the DOCA-salt rat, compared with normotensive controls. Our results suggest that spinally released glutamate mediates increased MAP during 48-h WD and DOCA-salt hypertension.
FORTY-EIGHT HOURS OF water deprivation (WD) and DOCA-salt hypertension are both accompanied by increased plasma osmolality (8, 24, 25, 38) , which is hypothesized to increase sympathetic nerve activity (SNA) and elevate mean arterial pressure (MAP) acutely and chronically [for reviews, see Stocker and colleagues (33, 37) ]. Consistent with this hypothesis, we recently reported that the pressor response to 48 h of WD in conscious rats is prevented by chronic adrenoreceptor blockade (39) . Evidence also suggests that DOCA-salt hypertension is mediated by osmotic activation of the sympathetic nervous system (24, 25) . The central pathways and neurotransmitters mediating osmotically driven sympathoexcitation and hypertension are incompletely understood. Elucidating these mechanisms is essential to understanding the etiology of saltsensitive hypertension and development of new therapies.
Work in recent years has identified brain pathways involved in osmotically driven increases in SNA, and the paraventricular nucleus (PVN), in particular, has been identified as an important region (33) . However, little is known about osmotically induced sympathetic activation at the level of the intermediolateral cell column (IML) of the spinal cord where sympathetic preganglionic nerves originate. Most evidence suggests there are two primary projections from the PVN that influence SNA during osmotic stress: a direct vasopressinergic projection from the PVN to the IML or a glutamatergic projection to the rostral ventrolateral medulla (RVLM) (2, 33, 38) . Therefore, the most likely neurotransmitters to drive IML neurons in response to increased plasma osmolality are vasopressin (from the PVN) and the neurotransmitters released by spinally projecting RVLM neurons.
Based on studies suggesting that a spinally projecting vasopressinergic pathway (13, 29, 32) from the PVN was activated in response to increased plasma osmolality (2), we recently investigated the role of spinal V1a receptors under conditions of osmotic stress in conscious rats (38) . We found that blockade of spinal V1a receptors had no effect on arterial pressure under conditions of 48 h of WD or DOCA-salt induced hypertension (38) . Therefore, despite neuroanatomical and neurophysiological evidence suggesting spinal vasopressin may be important in sympathetic regulation (2, 13, 29, 32) , we concluded that these receptors were not required for osmotically driven increases in arterial pressure in conscious rats.
Glutamate is thought to be the principal neurotransmitter in the spinally projecting RVLM pathway involved in regulating SNA and MAP (23) . Stimulation of the RVLM increases SNA with a timing that corresponds to fast excitatory neurotransmission like that of glutamate, and administration of glutamate receptor antagonists to the sympathetic preganglionic neuron (SPNs) inhibits their response to the RVLM stimulation (3, 22, 23) . Likewise, application of glutamate or its receptor agonists results in a depolarization and increased firing of SPNs (15, 23) , whereas glutamate receptor antagonists inhibit basal SPN activity (23) . Anatomically, glutamatergic nerve terminals from the RVLM have been localized in the IML (23) , and there is evidence that both N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors are located on SPNs (15) . Despite the abundance of evidence to suggest glutamate as the primary neurotransmitter regulating SPNs to affect MAP, this has not been examined under conditions of increased osmolality in conscious rats.
Therefore, the present study was conducted to test the hypothesis that spinally released glutamate mediates osmotically driven increases in MAP in conscious rats. Using a similar approach to that of our recent report of spinally released vasopressin (38), we delivered intrathecal (i.t.) antagonists to 48-h water-deprived and DOCA-salt hypertensive rats and examined the effects on MAP. Experiments were also conducted to confirm that the MAP responses to i.t. delivery of antagonists were mediated by actions in the spinal cord rather than the brain stem. Finally, we examined which excitatory amino acid receptor subtypes were involved in the MAP response to osmotic stress.
METHODS

Animals and General Protocols
Male Sprague-Dawley rats from Charles River Laboratory (Wilmington, MA) spent the duration of the experimental protocols singly housed in their home cages in a temperature-controlled animal room with a 12-h:12-h light/dark cycle. Unless otherwise noted, they had ad libitum access to normal rat chow (Lab Diet 5012) and deionized water. All protocols in this study were in accordance with the National Institutes of Health guidelines on animal research and were approved by the University of Minnesota's Institutional Animal Care and Use Committee.
General surgical procedures. All surgeries were performed under 2% isoflurane (following induction with 4%), and anesthesia depth was checked regularly by toe and tail pinch. Rats were given atropine sulfate (0.2 mg/kg ip, Baxter Healthcare) and gentamicin sulfate (2.0 mg im, Hospira) on the day of surgery. For 3 days postoperatively, amoxicillin (1 mg/ml, Westward Pharmaceutical) was added to the drinking water, and either buprenorphine (0.3 mg/ml in 0.02 ml, PharmaForce) or ketoprofen (2.5 mg/kg sc, Fort Dodge Animal Health) was administered for analgesia.
Rats were instrumented with radiotelemetry transmitters (model TA11PA-C40, Data Sciences International, St. Paul, MN) for continuous measurement of MAP and heart rate (HR). Transmitter catheters were implanted into the descending aorta by way of the femoral artery. Additionally, all rats received i.t. catheters to allow for drug delivery to the spinal cord. Briefly, a 32-gauge catheter (ReCathCo; Allison Park, PA) was inserted between L6 and S1 vertebrae and advanced 6.5-7 cm along the i.t. space until the tip lay between spinal segments T10 -T13. The catheter was attached to polyethylene-10 tubing (Intramedic TM; BD, Sparks, MD) and tunneled under skin to exit between the scapulae. It was then threaded through a spring and attached to a swivel above the rat's home cage to allow unrestricted movement throughout the protocol. Both the transmitter and i.t. catheter surgeries were previously described in greater detail (38) . The day before baseline data collection began, i.t. catheter placement was confirmed by transient hindlimb paralysis after administration of 20 l of lidocaine (10 mg/ml, Hospira) into the i.t. space; rats in which lidocaine did not elicit paralysis were eliminated from the study.
Unless otherwise noted, the rats in this study were conscious and freely moving in their home cages. For all of the experiments conducted in conscious rats, at least 5 days of recovery were given following surgery. Each cage was placed on a receiver (model RPC1) that was connected to a computer via a Data Exchange Matrix (DSI; St. Paul, MN). At the time of i.t. injections, MAP and HR data were continuously collected at 500 Hz over 10 s. Otherwise, MAP and HR data were collected for 10 s every 4 min at 500 Hz from the beginning of the protocol to the time of euthanasia. The i.t. injections in this study were given at a rate of ϳ0.5 l/s in volumes of 10 l followed by a flush of 25 l of artificial cerebrospinal fluid (ACSF). Upon completion of the study, rats were anesthetized with isoflurane, flushed with saline, and 10 l of Chicago Blue dye was injected into the i.t. catheter. The spinal cord and brain stem were exposed, and the tip of the catheter and spread of dye was carefully noted in each rat.
Experimental Protocols
Effect of i.t. kynurenic acid on arterial pressure and HR before and during WD. These experiments were designed to determine the effect of the nonspecific glutamate receptor antagonist kynurenic acid (kynurenate, KYN) on the pressor response to WD in conscious rats. The dose of i.t. KYN (50 mM) was based on a previously published study (40) . KYN was dissolved in NaOH and titrated to a final pH of 7.4. In pilot studies, we established that i.t. injection of the vehicle for KYN did not lower MAP (⌬MAP ϭ 10 Ϯ 4 mmHg at t ϭ 30 min) or HR (⌬HR ϭ 31 Ϯ 25 beats/min at t ϭ 30 min), similar to what we observed following i.t. ACSF (38) . Additionally, systemic (intravenous) administration of 50 mM KYN had no effect on MAP (⌬MAP ϭ Ϫ1 Ϯ 3 mmHg at t ϭ 30 min) or HR (⌬HR ϭ 2 Ϯ 21 beats/min at t ϭ 30 min). These results confirm that decreases in MAP or HR following i.t. KYN were not secondary to effects of vehicle or leakage into the systemic circulation.
Following recovery from surgery, MAP and HR were monitored for 2 days of baseline followed by 48 h of WD. Intrathecal KYN was administered at ϳ12:00 h on day 2 of baseline and day 2 of WD.
Effect of i.t. KYN on arterial pressure and HR in DOCA-salt rats. DOCA-salt rats were prepared as in a previous study from our group (26) . Briefly, the left kidney was exposed via a retroperitoneal incision; the renal artery, vein, and ureter were tied off and cut; and the kidney was removed. The muscle layer was closed, and a silicone pellet containing 50 mg of DOCA was cut into small pieces and placed subcutaneously. The skin incision was closed with surgical clips. In sham-operated rats, the left kidney was exposed, and a silicone pellet containing 0 mg DOCA was implanted subcutaneously. After surgery, rats were housed individually and given 0.1% sodium food and 0.9% NaCl ϩ 0.2% KCl solution to drink ad libitum. Sham-operated rats were given deionized water ad libitum. Three weeks later (day 23), transmitters and i.t. catheters were implanted as described above. On day 29, the MAP and HR responses to i.t. KYN were measured.
Comparison of the arterial pressure and HR responses to i.t. KYN injected in the lower and upper thoracic cord in anesthetized rats.
Since it is possible that i.t. KYN could diffuse to the brain stem, the cardiovascular responses to i.t. KYN could be due to blockade of glutamate actions on the sympathetic premotor neurons in the RVLM, rather than blockade of the spinal actions of glutamate. We reasoned that if this were the case, the MAP response to i.t. KYN in the upper thoracic cord would be similar to the responses to KYN injected in the lower thoracic cord.
The following protocol was conducted to address this possibility in isoflurane anesthetized rats. Telemetry transmitters and i.t. catheters were implanted as described above. In one group of rats (lower thoracic), the i.t. catheter was advanced 6.5-7 cm rostrally to segments T10 -T13 as described above. In another group of rats (upper thoracic), the catheter was advanced rostrally 10 cm so the tip was in the T1-T5 region. Isoflurane was maintained at 1.75-2% for the remainder of the experiment. Anesthesia depth was verified every 15 min by lack of response to tail pinch. Following a 20-min stable recording period, i.t. KYN was administered and MAP and HR were monitored over a 30-min postinjection period.
Contribution of excitatory amino acid receptor subtypes to the regulation of arterial pressure and HR pressor during WD. Since KYN can block both NMDA and non-NMDA receptor subtypes (35) , the goal of these experiments was to examine whether NMDA and/or non-NMDA receptor blockade affected the pressor response to WD. Following the same protocol as the WD experiment described above, on day 2 of baseline and day 2 of WD, rats received i.t. administration of the specific NMDA receptor antagonist DL-2-amino-5-phosphonopentanoic acid (AP-5) or the specific non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX).
Doses for AP-5 (20 mM) and CNQX (5 mM) were based on published reports (11, 14) and preliminary studies in two groups of isoflurane anesthetized rats. Anesthesia was used in these dosedetermining pilot studies because i.t. injection of excitatory amino acid agonists may produce hyperalgesia and somatic motor responses in conscious rats (5) . In one group, responses to i.t. NMDA (10 mM) or ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA; 50 M) were measured 5 min after vehicle pretreatment (i.t. ACSF). In the second group, one of the antagonists (AP-5 or CNQX) was administered and then, 5 min later, the appropriate agonist (NMDA or AMPA) was administered.
Drugs
Unless otherwise noted, the drugs used in this study were purchased from Sigma-Aldrich (St. Louis, MO). The drugs used were ACSF (Harvard Apparatus, Holliston, MA), KYN, NMDA, AP-5, AMPA, and CNQX.
Data Analysis and Statistics
Dataquest A.R.T. 4.0 software (DSI) was used to acquire and analyze the MAP and HR data. SigmaStat software (v. 3.5, San Jose, CA) was used to identify statistical differences. For all comparisons, a P value of Ͻ0.05 was defined as statistically significant.
Experiments in water-deprived rats followed a within-animal design, whereas protocols in anesthetized rats and DOCA-salt rats followed a between-animal design. MAP and HR responses to i.t. injections were plotted at 2-min intervals as the difference from baseline. The data were analyzed using a two-way repeated-measures ANOVA with the Holm-Sidak post hoc test. The t ϭ Ϫ6 min time point was used as the control within groups. The maximum MAP effects occurred at approximately t ϭ 30 min for i.t. KYN, t ϭ 6 min for i.t. AP-5, and t ϭ 10 min for CNQX. Therefore, time points were used to report the effects of the i.t. injections. Absolute values (Table 1) were analyzed for statistical significance using the Student's t-test. Table 1 shows the absolute values of (baseline) MAP and HR before (water replete) and after 48 h of WD. WD increased MAP by ϳ15 mmHg; HR tended to decrease with WD, but this was not significant. These responses are in agreement with our previously published studies (38, 39) and were consistent across all of the WD experiments in the present study.
RESULTS
Effect of i.t. KYN on Arterial Pressure and HR Before and During WD
The MAP and HR responses to i.t. KYN before and during WD are shown in Fig. 1 . In the water-replete state (before WD), i.t. KYN decreased MAP by ϳ20 mmHg and HR by ϳ100 beats/min. After 48 h of WD, i.t. KYN decreased MAP by ϳ50 mmHg and HR by ϳ100 beats/min. The KYN-induced fall in MAP was significantly greater during the water-deprived state compared with the water-replete state (Fig. 1) . The absolute MAP and HR values after i.t. KYN (at t ϭ 30 min) are reported in Table 1 . Intrathecal KYN decreased MAP and HR to significantly lower absolute values in the water-deprived group.
It is important to note that i.t. KYN caused motor impairment in both water-replete and water-deprived rats, particularly in the hindlimbs. Hindlimb dysfunction appeared between 5-10 min after i.t. KYN, and all rats showed hindlimb paralysis by 15 min. In contrast, forelimb paralysis did not occur in all rats; when it did, it typically began between 20 -30 min after i.t. KYN. Motor impairment was sustained for the duration of the data collection (60 min after i.t. KYN).
Effect of i.t. KYN on Arterial Pressure and HR in DOCA-salt Rats
As shown in Table 1 (baseline values), MAP was significantly higher in DOCA-salt rats compared with sham-operated rats, but there was no significant difference in HR. Figure 2 shows the MAP and HR responses to i.t. KYN. Intrathecal KYN decreased MAP significantly more in DOCA-salt rats (ϳ50 mmHg) than in the sham-operated rat group (ϳ20 mmHg). Similarly, the response of HR in DOCA-salt rats (ϳ100 beats/min) was significantly more than that in the sham-operated rats. The responses to i.t. KYN are reported in absolute values (at t ϭ 30 min) in Table 1 . Finally, i.t. KYN also caused motor impairment in both sham-operated and DOCA-salt rats with a timing similar to the motor impairment described in the WD experiment.
Comparison of the Arterial Pressure and HR Responses to i.t. KYN Injected at Lower and Upper Thoracic Levels in Anesthetized Rats
We investigated the possibility that the effects of i.t. KYN were due to diffusion of KYN to the brain stem rather than actions in the spinal cord. We reasoned that if i.t. KYN decreased MAP by acting in the brain stem, injections in the upper thoracic cord would produce responses similar to injections at the lower thoracic cord. However, we observed the opposite (Fig. 3) . Rats with the catheter placed near spinal segments T1-T5 exhibited a much smaller MAP response to i.t. KYN compared with rats with catheters placed in the T10 -T13 region of the cord. Although there were no significant differences in HR between groups, the decrease in HR tended to fall at an earlier time point in rats with the upper thoracic catheter. Catheter placement was confirmed postmortem. Blue dye was seen throughout the thoracic spinal region in rats with the catheter in the lower thoracic region. In contrast, catheters placed in the upper thoracic cord showed most of the blue dye in the upper thoracic and cervical segments, with some dye in brain stem regions and only faint dye in the lower thoracic segments.
Contribution of Excitatory Amino Acid Receptor Sub-types to the Regulation of Arterial Pressure and HR Pressor During WD
Doses of NMDA receptor and non-NMDA receptor antagonists were determined in pilot studies in anesthetized, euhydrated rats (n ϭ 2/group). Intrathecal administration of NMDA (10 mM) increased MAP by 45 Ϯ 18 mmHg (at t ϭ 6 min), and this response was prevented by pretreatment with 20 mM AP-5 (Ϫ15 Ϯ 8 mmHg at t ϭ 6 min). In contrast, i.t. administration of AMPA (50 M) increased MAP by 11 Ϯ 2 mmHg (at t ϭ 6 min), and increasing the dose of AMPA by 100-fold did not affect the magnitude of response. The response to AMPA was prevented by pretreatment with 5 mM CNQX (Ϫ1 Ϯ 1 mmHg at t ϭ 6 min). Therefore, these doses of AP-5 and CNQX were selected for administration in conscious, water-deprived rats. Figure 4 shows that i.t. AP-5 had no significant effect on MAP in water-replete rats but significantly decreased MAP after 48 h of WD (at t ϭ 6 min, ⌬MAP ϭ Ϫ13 Ϯ 4 mmHg). HR was not significantly affected by AP-5 during water-replete or water-deprived conditions (Fig. 4) . In contrast to AP-5, i.t. CNQX unexpectedly caused an increase in MAP (ϳ10 mmHg) and HR (ϳ75 beats/min) in both water-replete and waterdeprived conscious rats (data not shown). This response was associated with noticeable behavioral and motor responses, particularly hindlimb scratching, that compromised the interpretation of the cardiovascular effects. There was no difference between the water-replete and water-deprived responses to i.t. CNQX (data not shown).
DISCUSSION
The present study was conducted to investigate the role of spinally released glutamate under conditions of osmotic stress. We found that blockade of glutamate receptors with i.t. KYN resulted in a significantly greater fall in arterial pressure after 48 h of WD compared with the water-replete state. Likewise, DOCA-salt rats showed a significantly greater fall in pressure in response to i.t. KYN than the normotensive sham-operated rats. Finally, blockade of NMDA receptors attenuated arterial pressure in the water-deprived, but not water-replete, state, suggesting the pressor response to WD relies, at least in part, on NMDA receptors.
Effect of i.t. KYN on Arterial Pressure and HR Before and During WD
In agreement with our previous studies (38, 39), 48 h of WD increased arterial pressure by ϳ15 mmHg above baseline. In contrast to our report that blockade of spinal V1a receptors had no effect on arterial pressure in water-deprived rats (38) , we observed in the present study that i.t. KYN decreased arterial pressure significantly more after 48-h of WD than in the water-replete state. Taken together, these studies suggest that spinally released glutamate, but not vasopressin, is responsible for the elevation of arterial pressure during WD. Interestingly, Kawabe et al. (16) came to a similar conclusion about these spinally released neurotransmitters; they demonstrated that the pressor response and tachycardia elicited by PVN stimulation in anesthetized rats were mediated by spinal ionotropic glutamate receptors and not vasopressin receptors.
One complicating factor in interpreting the magnitude of the decrease in arterial pressure as a reflection of sympathetic activity is that other factors may play a role. For example, although arterial pressure was elevated after 48 h of WD, the absolute level of arterial pressure fell to a lower level after i.t. KYN compared with water-replete conditions. One explanation for this may be that blood volume is reduced in waterdeprived rats, so vasodilation secondary to decreased SNA with i.t. KYN results in a lower arterial pressure than in the normovolemic, water-replete state. Although this would contribute to the magnitude of change in arterial pressure following i.t. KYN (in addition to the neurogenic component), it does not change our interpretation that the increase in arterial pressure after 48 h of WD is reversed by i.t. KYN.
We observed that i.t. KYN decreased arterial pressure in water replete rats ϳ20 mmHg with the maximum fall occurring at ϳ15 min. This is a smaller and faster response than that reported by Verberne et al. (40) using the same dose of KYN in conscious rats. Similarly, the HR response we observed in the water-replete rats was smaller and faster than that reported by Verberne et al. (40) . In that study, the catheter tip was positioned at segments T8 -T10, in contrast to our study in which the tip was positioned at segments T10 -T13. Another possible explanation is that the injection rate may have been different, which would have affected the rostral-caudal spread of injected KYN. A third difference between these studies was in the technique used to measure arterial pressure. Verberne et al. (40) measured arterial pressure directly through an aortic cannula connected to an external pressure transducer after rats were moved to a separate experimental room, which may have induced a stress response. In contrast, our studies were conducted by telemetry while rats rested in their home cages.
A final point worth mentioning is the possibility that i.t. KYN could hyperpolarize the SPNs to an extent at which they cannot be activated by any neurotransmitter. We cannot completely rule out this possibility; however, an i.t. injection of a V1a agonist acutely increased arterial pressure despite pretreatment with i.t. KYN (unpublished observations, n ϭ 3). This suggests that other spinal neurotransmitters, acting independently from glutamate, still have the ability to influence MAP after i.t. KYN.
Effect of i.t. KYN on Arterial Pressure and HR in DOCA-salt Rats
Similar to water-deprived rats, i.t. KYN caused a greater decrease in arterial pressure in hypertensive DOCA-salt rats than in normotensive sham-operated rats. Intrathecal KYN was administered after 4 wk of DOCA-salt treatment, well into the established phase of hypertension (1), suggesting that spinal glutamate receptors are involved in the maintenance of hypertension in DOCA-salt rats. However, whether spinally released glutamate is involved in the developmental phase of DOCAsalt hypertension remains to be determined. The bradycardic effect of i.t. KYN in sham-operated rats was blunted compared with the euhydrated rats in the other experiments of this study. This resulted in a significant difference in the HR effects of i.t. KYN between sham-operated and DOCA-salt rats, but an explanation for this effect is not readily apparent.
We previously reported that blockade of spinal V1a receptors has no effect on arterial pressure in DOCA-salt rats (39) despite implications that the PVN mediates increased sympathetic activity in this model (1) . Taken together, these findings suggest that, although increased activity of the PVN in DOCAsalt hypertension may occur, increased arterial pressure in this model is not driven by spinally projecting vasopressinergic neurons from the PVN. The results of the present study are more consistent with the hypothesis that glutamatergic inputs to spinal SPNs, perhaps from the RVLM, mediate increased sympathetic activity in DOCA-salt rats. Further studies are needed to test this hypothesis.
It is important to note that absolute level of arterial pressure after i.t. KYN was higher in DOCA-salt rats than shamoperated rats. This is consistent with the idea that DOCA-salt hypertension is not entirely mediated by increased sympathetic activity and that another mechanism, such as increased plasma vasopressin (1, 4, 25) , also contributes to maintenance of hypertension in DOCA-salt rats.
Contribution of Excitatory Amino Acid Receptor Subtypes to the Regulation of Arterial Pressure and HR Pressor During WD
Since KYN is a nonspecific antagonist of ionotropic glutamate receptors (35), we attempted to investigate the contribution of NMDA and non-NMDA receptors to the pressor response to WD. AP-5, a specific NMDA receptor antagonist, had no effect on arterial pressure in the water-replete state but significantly decreased arterial pressure in water-deprived rats for ϳ10 min. This finding suggests that spinal NMDA receptors are involved in the arterial pressure response to WD, but it is not readily apparent why the response to AP-5 had such a short duration. To our knowledge, the cardiovascular responses to i.t. AP-5 in conscious rats have not been previously reported. In anesthetized rats, i.t. AP-5 (200 nmol) decreases arterial pressure by ϳ10 -20 mmHg, which lasts ϳ30 min (14) . This is in agreement with results of our pilot studies in anesthetized rats with the same dose. While the duration and magnitude of the i.t. AP-5 effects were much less than those of i.t. KYN, it is impossible to compare the two antagonists since complete dose-response curves were not obtained. Therefore, the i.t. AP-5 results can be interpreted as evidence that NMDA receptors play a role in mediating MAP during WD; however, more quantitative conclusions will require further investigation.
We also investigated the cardiovascular responses to i.t. CNQX, an antagonist for non-NMDA receptors. The dose of CNQX used (5 mM) had no significant effect on MAP or HR in isoflurane anesthetized rats, similar to findings by Feldman et al. (11) who reported no change in MAP or HR with i.t. CNQX (1 and 10 mM) in anesthetized rats (11) . Unfortunately, the results of experiments in conscious rats were uninterpretable due to increased motor activity and scratching, suggesting the rats may have experienced pruritis or analgesia in response to i.t. CNQX. As a result, CNQX increased both MAP and HR during baseline and water-deprived periods. Because of these behavioral responses to i.t. CNQX, the contribution of non-NMDA receptors to the regulation of MAP during WD in conscious rats remains unclear.
Putative Sites of Action Mediating the Cardiovascular Responses to i.t. KYN
Intrathecal catheterization is a useful technique for studying functional outcomes of spinal neuronal activation or inhibition in conscious animals. However, it is not possible to know the precise site of action of the injectate either along the rostralcaudal axis of the spinal cord or across a single segment (i.e., IML, ventral, and dorsal horns). Therefore, we cannot conclude that the effects of i.t. KYN on MAP were due to blockade of the actions of glutamate on SPNs specifically. Indeed, spinal interneurons are thought to receive glutamatergic input (19) , and glutamate labeling remains following spinal transection (18, 19, 21) , suggesting that not all spinally released glutamate comes from supraspinal sites. Therefore, although our results demonstrate that glutamate receptors mediate the pressor responses to WD and DOCA-salt treatment, further studies are needed to identify the specific KYN-sensitive spinal neurons involved.
The rostral-caudal distribution of intrathecally administered KYN is particularly important in this study because evidence suggests that sympathetic premotor neurons in the RVLM are regulated by glutamatergic neurons from the PVN during osmotic stress (6, 7, 34) . This raises the possibility that the effects of i.t. KYN in this study were secondary to blockade of glutamate receptors in the RVLM or other brain stem nuclei, rather than the spinal cord. We addressed this possibility in anesthetized rats by comparing the i.t. KYN responses administered through catheters in the lower thoracic cord (segments T10 -T13; the same location as the catheters in the other experiments in this study) to those in the upper thoracic cord (segments T1-T5). We reasoned that, if the cardiovascular responses were due to glutamate receptor blockade in the brain stem, the MAP response to administration of KYN in the upper thoracic cord would be the same or greater than that observed in response to injections in the lower thoracic cord. However, we observed the opposite; the decrease in MAP following injection of KYN to the upper thoracic cord was significantly less compared with injections in the lower thoracic cord. This suggests that the majority of the MAP response to KYN is due to action in the lower thoracic spinal cord. This is in agreement with the postmortem analysis of dye spread, which showed minimal dye below T6 in rats with upper thoracic catheters. The HR in the upper thoracic group fell sooner than that of the lower thoracic group, which was likely due to their closer proximity to the cardiac preganglionic neurons located in T1-T5 segments. However, the magnitude of the HR responses was similar between the two catheter locations, suggesting that the KYN from both injection sites ultimately had equal access to the cardiac SPNs. This is also in agreement with the postmortem dye analysis, which indicated that lower thoracic injections generally spread through, but not beyond, the tho-racic spinal cord region, whereas the upper thoracic injections affected the upper thoracic, cervical, and possibly brain stem regions. We conclude that the MAP response to i.t. KYN in conscious rats is mostly, if not entirely, due to blockade of glutamate receptors in the spinal cord and that much of the response appears to be mediated by receptors in the lower thoracic region. This is in agreement with Kawabe et al. (16) who found that blockade of glutamate receptors in levels T1-T4 had no effect on the MAP response to PVN stimulation, but i.t. glutamate antagonists administered near T9 and T10 completely blocked the response (16) . It is also in agreement with previous studies demonstrating that KYN administered directly into the RVLM of normal rats has minimal effects on MAP (10, 36) .
Finally, in addition to cardiovascular responses, i.t. KYN caused motor paralysis, particularly in the hindlimbs. This is consistent with the findings from Verberne et al. in conscious rats and may be due to blockade of NMDA receptors in lumbar neurons (9, 40) . Interestingly, the timing of the forelimb paralysis serves as a rough indicator of the rostral spread of KYN. We observed the majority of the fall in MAP occurs within 15 min of i.t. KYN, before forelimb paralysis that typically occurs between 20 and 30 min postinjection. In other words, diffusion of the injectate to the most rostral cord appears to occur after the maximal MAP response. This observation is consistent with the results of the upper/lower thoracic injections that indicated that the MAP response is due to a spinal action. Additionally, it is unlikely that the cardiovascular effects of i.t. KYN are secondary to motor paralysis since we observed the same cardiovascular responses in anesthetized rats in the upper/lower thoracic experiment.
Perspectives
The results of this study further support the idea that spinal glutamate is an important regulator of SNA and MAP. To our knowledge, these are the first studies in conscious rats investigating the role of spinal glutamate in regulation of MAP under hyperosmotic conditions. It is important to note that the hyperosmotic conditions used in this study, WD and DOCAsalt hypertension, involve other complex neurohumoral responses that are incompletely understood. Therefore, the spinal glutamate actions that drive the pressor responses during these conditions may not be specifically due to increased osmolality. However, osmolality is likely the initiating trigger because it is increased in both of our tested conditions and is thought to activate neural pathways that affect SNA and MAP (33) .
A direct vasopressinergic pathway from the PVN to the spinal cord has been hypothesized to play a role in regulating MAP (27, 28, 30, 41) during osmotic stress (2, 12, 31, 33, 37) . However, our recent findings (38) combined with the present study suggests that spinal glutamate, but not vasopressin, receptors are required for the pressor responses to increased osmolality in conscious rats. Although these findings may support the hypothesis that the RVLM spinal pathway (rather than a PVN spinal pathway) is activated during osmotic stress, two alternative explanations are evident. First, the data here could reflect antagonism of glutamate receptors on interneurons rather than SPNs, as evidence suggests that interneurons receive glutamatergic input (19) . Additionally, since interneurons themselves express mRNA for vesicular glutamate transporter 2 (17), the findings here could result from blocking the effects of interneurons projecting to SPNs. Second, the supraspinal glutamatergic neurons involved could arise from regions other than the RVLM, including, perhaps, the PVN (40) . Indeed, findings suggest that vesicular glutamate transporter-2 mRNA is expressed in the RVLM, PVN, and raphe nucleus, which all innervate the IML (17) . Moreover, all excitatory neurons that synapse on SPNs likely contain glutamate (20) . Therefore, the source of the glutamate that is blocked by i.t. KYN in this study remains unknown. Whether other neuropeptides, besides vasopressin, interact with glutamate and are required in the pressor responses to osmotic stress also remains to be determined. The spinal cord has the potential to act as a novel therapeutic target for the treatment of hypertension and other diseases associated with increased sympathetic activity; understanding the spinal mechanisms that contribute to sympathetic outflow is an important first step.
